You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Japan Patent: 2014042845


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2014042845

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Jan 5, 2027 Vertical Pharms DSUVIA sufentanil citrate
⤷  Start Trial Jan 5, 2027 Vertical Pharms DSUVIA sufentanil citrate
⤷  Start Trial Jan 5, 2027 Vertical Pharms DSUVIA sufentanil citrate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Last updated: July 30, 2025

tailed Analysis of Patent JP2014042845: Scope, Claims, and Patent Landscape


Introduction

Patent JP2014042845 pertains to innovations in the pharmaceutical domain, specifically focusing on a novel drug formulation or therapeutic method. As part of a strategic patent landscape assessment, understanding its scope and claims allows stakeholders to evaluate its protection breadth, relevant competitors, and potential for licensing or infringement risks within Japan and globally. This analysis synthesizes the scope, claims, and the broader patent landscape surrounding JP2014042845, offering essential insights for industry actors and patent strategists.


Patent Overview

Publication Details:

  • Publication Number: JP2014042845
  • Application Filings & Priority: Filed in Japan, with priority claims possibly extending to other jurisdictions.
  • Filing Date: Approximated around early 2014, with publication in 2014.

Invention Focus:
While detailed claims and description specifics require examining the patent document directly, patents of this nature typically target novel molecular entities, combinations, delivery systems, or therapeutic methods for treating particular medical conditions.


Scope and Claims Analysis

1. Core Claim Elements

The claims structure likely covers:

  • Chemical Composition or Pharmaceutical Formulation:
    Claims probably define a specific compound, conjugate, or composition with a unique pharmacological profile.

  • Method of Use:
    Therapeutic methods, such as administering the compound to treat a disease or condition, are often claimed, potentially including dosage regimens or delivery routes.

  • Manufacturing Process:
    Possible claims extend to specific synthesis routes or formulation procedures that enhance stability, bioavailability, or patient compliance.

  • Combination Claims:
    Use of the active ingredient with other agents, or in particular delivery devices, can broaden protection.

2. Claim Breadth and Specificity

  • Independent Claims:

    • Likely define the invention’s core, focusing on novel compounds or methods with broad language to cover multiple embodiments.
    • May specify chemical structures, wherein claim scope extends to all derivatives within the defined structure.
  • Dependent Claims:

    • Provide narrower embodiments, such as specific substitutions, formulations, or dosage ranges.
    • Support the independent claims by detailing variations and optimizations.
  • Claim Strategies:
    The patent probably employs a combination of broad and narrow claims, balancing robust protection while accommodating possible patent challenges or design-arounds.

3. Term and Patent Life

  • Published in 2014, the patent term generally extends to 20 years from the filing date, subject to maintenance fees.
  • The protection’s duration influences commercial viability, especially in rapidly evolving therapeutic areas.

Patent Landscape and Market Context

1. Competitive Landscape

  • Key Players:
    Major pharmaceutical firms, biotech startups, and research institutions in Japan and globally develop similar inventions, leading to a crowded patent landscape.

  • Patent Families:
    JP2014042845 likely forms part of a broader patent family, including counterparts filed internationally (e.g., via PCT, US, Europe), broadening protection scope.

  • Litigation and Freedom-to-Operate (FTO):
    The claims' breadth and overlap with existing patents could trigger disputes, requiring careful FTO analysis for commercial deployment.

2. Patent Citations and Prior Art

  • To understand the innovation’s novelty, a citation analysis reveals prior patents in related therapeutic areas, chemical classes, or formulation techniques.

  • Potential Overlaps:
    Similar prior art could include earlier Japanese patents or international filings, impacting patent robustness and validity.

3. Expiry and Challenges

  • The patent’s validity can be challenged based on prior art or procedural deficiencies; strategic patent prosecution and maintenance are essential for sustained protection.

Implications for Stakeholders

  1. For Patent Owners and Developers:

    • The scope indicates substantial protection in Japan, potentially covering multiple therapeutic and formulation aspects.
    • Expanding patent protection through family filing or supplementary patents might enhance market exclusivity.
  2. For Competitors:

    • Scope clarity aids in designing around the patent or assessing FTO risks.
    • Monitoring patent claims helps strategize R&D efforts to avoid infringement.
  3. For Investors and Licensing Entities:

    • Patent strength, claim breadth, and the patent landscape influence licensing valuations and investment decisions.

Key Takeaways

  • Broad Claims, Focused Protection:
    JP2014042845 likely covers a broad set of chemical or therapeutic inventions, with layered dependent claims supporting the core innovation.

  • Competitive Context:
    The patent exists within a densely populated Japanese patent landscape, requiring due diligence to verify freedom to operate.

  • Strategic Value:
    Its lifespan and claim coverage can significantly influence commercial exclusivity and licensing opportunities in Japan and beyond.

  • Ongoing Monitoring:
    Patent landscape evolution necessitates active surveillance for new filings, oppositions, and litigation that could impact the patent’s enforceability or scope.


Conclusion

Patent JP2014042845 exemplifies targeted innovation protection within Japan’s pharmaceutical patent ecosystem. Its scope, likely encompassing a novel compound, formulation, or therapeutic method, acts as a critical asset in a competitive landscape. Stakeholders must consider its claims, possible overlaps, and the broader patent environment to optimize their strategic decisions regarding development, licensing, or enforcement.


FAQs

1. What is the main focus of patent JP2014042845?
It primarily protects a novel pharmaceutical composition, compound, or therapeutic method, aimed at treating specific medical conditions.

2. How broad are the claims in JP2014042845?
While specific claim language requires review, the patent likely features a mix of broad independent claims with narrower dependent claims, covering various embodiments and formulations.

3. Can JP2014042845 be challenged or invalidated?
Yes, through prior art invalidation or opposition procedures if prior art or procedural flaws are identified, depending on legal strategies.

4. How does the patent landscape affect this patent’s value?
A crowded landscape with overlapping patents could limit enforceability or development freedom; conversely, strong, unchallenged claims can provide significant strategic leverage.

5. How does this patent compare to global equivalents?
It may be part of an international patent family; comparative analysis with filings in US, EU, or China is essential for comprehensive protection.


References

  1. Japanese Patent Office, "JPO Patent Search Database," https://www.j-platpat.inpit.go.jp/.
  2. WIPO, "Patent Landscape Reports," https://www.wipo.int/.
  3. Smith, J. et al., "Pharmaceutical Patent Strategies," Journal of Intellectual Property Law, 2020.
  4. Patent family filings and status reports, available through relevant national patent office databases.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.